RESULTS IN ALL CASES OF CANCER
Response	Number	Percent
Complete Regression (C-R)	31 / 254	12.2 %
Partial Regression (P-R)	103 / 254	40.6%
Minor Response (M-R)	33 / 254	12.9 %
Stable Disease (S-D)	34 / 254	13.4 %
Progression (PROGR.)	26 / 254	10.2 %
Treatment not started (T-N-S)	27 / 254	10.7 %

RESULTS IN OVARIAN CARCINOMA PATIENTS
Response	Percent
Complete Regression (C-R)	10.9 %
Partial Regression (P-R)	41.3%
Minor Response (M-R)	10.7 %
Stable Disease (S-D)	17.8 %
Progression (PROGR.)	5.8 %
Treatment not started (T-N-S)	13.5 %

RESULTS IN BREAST CANCER PATIENTS
Response	Percent
Complete Regression (C-R)	13.8 %
Partial Regression (P-R)	48.2%
Minor Response (M-R)	13.6 %
Stable Disease (S-D)	10.4 %
Progression (PROGR.)	9.2 %
Treatment not started (T-N-S)	4.8 %

RESULTS IN COLORECTAL CANCER PATIENTS
Response	Percent
Complete Regression (C-R)	8.7 %
Partial Regression (P-R)	21.2%
Minor Response (M-R)	12.3 %
Stable Disease (S-D)	15.3 %
Progression (PROGR.)	30.3 %
Treatment not started (T-N-S)	12.2 %

RESPONSE IN BRONCHIAL CARCINOMA PATIENTS
Response	Percent
Complete Regression (C-R)	10.3 %
Partial Regression (P-R)	65.8 %
Minor Response (M-R)	6.2 %
Stable Disease (S-D)	5.3 %
Progression (PROGR.)	3.1 %
Treatment not started (T-N-S)	9.3 %

RESPONSE IN PANCREATIC CARCINOMA PATIENTS
Response	Percent
Complete Regression (C-R)	17.3 %
Partial Regression (P-R)	31.4 %
Minor Response (M-R)	11.2 %
Stable Disease (S-D)	17.9 %
Progression (PROGR.)	8.7 %
Treatment not started (T-N-S)	13.5 %